Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

7.70USD
18 Jan 2019
Change (% chg)

$0.08 (+1.05%)
Prev Close
$7.62
Open
$7.67
Day's High
$7.74
Day's Low
$7.45
Volume
44,711
Avg. Vol
55,923
52-wk High
$14.90
52-wk Low
$6.65

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 195.02 33.71
EPS (TTM): -0.37 -- --
ROI: -77.87 9.63 14.48
ROE: -162.40 15.55 15.99

Earnings vs. Estimates